gimli

SUDEEPPHRM stock AI analysis

SUDEEPPHRM Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

SUDEEP PHARMA LIMITED is a small-cap stock in Chemicals. This Gimli page shows the latest available SUDEEPPHRM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive SUDEEPPHRM stock page

Price

₹866.45

1W return

+2.23%

1M return

+2.79%

3M return

+30.38%

6M return

+63.48%

1Y return

n/a

Market cap

₹9,786.43 cr

56.38

14.10

ROE

+40.89%

ROCE

+20.33%

RSI

60.08

Turnover

₹5.42 cr

Why it can matter in screens

Momentum: SUDEEPPHRM is above 50DMA, below 200DMA; RSI is 60.08.
Returns: 1D +0.43%, 1W +2.23%, 1M +2.79%, 3M +30.38%, 1Y n/a.
Trend levels: 52W high ₹883.35, 52W low ₹530.00, off high -1.91%.
Liquidity: latest turnover is ₹5.42 cr; volume vs 20D is +0.33%.
Valuation/profitability: PE 56.38, PB 14.10, ROE +40.89%, ROCE +20.33%.
Growth: 3Y sales CAGR +12.11%, 3Y profit CAGR +38.40%.

Quick Answers

What is the latest SUDEEPPHRM stock price?

The latest stored price for SUDEEPPHRM is Rs 866.45 as of 2026-07-20.

Is SUDEEPPHRM above its 50DMA and 200DMA?

SUDEEPPHRM is above 50DMA, below 200DMA. The latest 50DMA is 769.97 and the latest 200DMA is n/a.

What are SUDEEPPHRM PE, ROE and ROCE?

SUDEEPPHRM has PE 56.38, ROE +40.89%, and ROCE +20.33% in Gimli's latest available snapshot.

How has SUDEEPPHRM performed recently?

SUDEEPPHRM has returned +2.79% over 1 month, +30.38% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	188.76 cr	69.02 cr	48.54 cr	4.38
2025-12-31	172.34 cr	66.81 cr	47.46 cr	4.29
2025-09-30	172.84 cr	65.63 cr	46.78 cr	4.20
2025-06-30	124.19 cr	48.53 cr	30.81 cr	2.73
2025-03-31	152.96 cr	61.35 cr	44.15 cr	nan
2024-12-31	115.54 cr	41.73 cr	28.71 cr	2.54

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-03-31	497.41 cr	198.09 cr	138.69 cr	12.28
2024-03-31	454.67 cr	186.90 cr	133.19 cr	11.79
2023-03-31	426.17 cr	97.30 cr	62.32 cr	5.52
2022-03-31	353.02 cr	76.22 cr	52.31 cr	371.20

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-03-31	717.17 cr	36.81 cr	137.55 cr	493.09 cr
2024-03-31	513.87 cr	13.98 cr	78.08 cr	356.03 cr
2023-03-31	420.11 cr	10.30 cr	83.08 cr	223.28 cr

Cash flow

Period	OCF	FCF	Cash change
2025-03-31	48.73 cr	-15.51 cr	n/a
2024-03-31	65.69 cr	13.22 cr	n/a
2023-03-31	48.40 cr	1.24 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+76.15%	+1.55%	+18.11%	+6.19%	+4.18%	+0.00%
2025-12-31	+76.15%	+1.67%	+17.60%	+5.67%	+4.58%	+0.00%
2025-11-27	+76.15%	+1.54%	+14.76%	+3.44%	+7.54%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	172,184.56 cr	102.640495	+30.27%	+27.65%
PIDILITIND	PIDILITE INDUSTRIES LTD	159,363.26 cr	64.932529	+23.37%	+5.87%
SRF	SRF LTD	85,118.91 cr	46.381778	+13.76%	-9.90%
LINDEINDIA	LINDE INDIA LIMITED	59,669.09 cr	108.694787	+13.58%	+4.37%
COROMANDEL	COROMANDEL INTERNTL. LTD	59,544.89 cr	30.625989	+15.97%	-12.57%
FACT	FACT LTD	53,784.62 cr	-1358.197592	-2.91%	-12.86%
UPL	UPL LIMITED	51,160.88 cr	25.825785	+5.01%	-11.76%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	47,413.46 cr	82.030202	+7.60%	+23.34%

Try these prompts

Analyze SUDEEP PHARMA with valuation, momentum and industry peers
Compare SUDEEPPHRM with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-20. Not investment advice.